Compare LUNR & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUNR | VCYT |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | N/A | 2013 |
| Metric | LUNR | VCYT |
|---|---|---|
| Price | $17.53 | $36.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $18.00 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 12.0M | 871.5K |
| Earning Date | 03-23-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $219,936,000.00 | ★ $495,141,000.00 |
| Revenue This Year | N/A | $16.72 |
| Revenue Next Year | $229.04 | $11.31 |
| P/E Ratio | ★ N/A | $95.13 |
| Revenue Growth | 7.85 | ★ 16.41 |
| 52 Week Low | $6.14 | $22.61 |
| 52 Week High | $23.32 | $50.71 |
| Indicator | LUNR | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 32.81 |
| Support Level | $14.54 | $34.71 |
| Resistance Level | $19.69 | $38.98 |
| Average True Range (ATR) | 2.15 | 1.76 |
| MACD | -0.85 | -0.58 |
| Stochastic Oscillator | 10.37 | 10.42 |
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.